Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants
- 1 November 2021
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (11), 1493-1502
- https://doi.org/10.7326/m21-1474
Abstract
Previous real-world studies comparing gastrointestinal bleeding (GIB) among direct oral anticoagulants (DOACs) have suggested that rivaroxaban has a higher percentage of GIB than other DOACs, but t... Visual Rivaroxaban Has Higher GIB Rates Than Other DOACs. Previous real-world studies comparing gastrointestinal bleeding (GIB) among direct oral anticoagulants (DOACs) have suggested that... Background: Gastrointestinal bleeding (GIB) rates for direct oral anticoagulants (DOACs) and warfarin have been extensively compared. However, population-based studies comparing GIB rates among dif...This publication has 49 references indexed in Scilit:
- Lower gastrointestinal bleedingEuropean Journal of Gastroenterology & Hepatology, 2013
- Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based settingScandinavian Journal of Gastroenterology, 2012
- Effect of dosing frequency on chronic cardiovascular disease medication adherenceCurrent Medical Research and Opinion, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationThe New England Journal of Medicine, 2011
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Validation of a Case Definition to Define Hypertension Using Administrative DataHypertension, 2009
- Dabigatran versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2009
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987